Efficacy of dacomitinib on rechallenge as EGFR-TKI to NSCLC with EGFR mutation except of T790M mutation

Taro Yoneda

[P28-12] Efficacy of dacomitinib on rechallenge as EGFR-TKI to NSCLC with EGFR mutation except of T790M mutation

^○Taro Yoneda¹, Hayato Koba¹, Tsukasa Ueda², Chihoka Nakai¹, Hiroko Morita¹, Hideharu Kimura³, Kazuo Kasahara³ (1.Respiratory Medicine, Komatsu Municipal Hospital, 2.Respiratory Medicine,Fukui-ken Saiseikai Hospital, 3.Respiratory Medicine, Kanazawa University Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Presentation information

[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-12] Efficacy of dacomitinib on rechallenge as EGFR-TKI to NSCLC with EGFR mutation except of T790M mutation

Password

Presentation information

[P28] Poster Session 28 Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-12] Efficacy of dacomitinib on rechallenge as EGFR-TKI to NSCLC with EGFR mutation except of T790M mutation

Password

[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）